Company Filing History:
Years Active: 2016
Title: Aviva Gross: Innovator in Parenteral Formulations
Introduction
Aviva Gross is a notable inventor based in Kiryat Tivon, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of parenteral formulations. Her work focuses on enhancing therapeutic efficacy while minimizing side effects.
Latest Patents
Aviva Gross holds 1 patent for her innovative work titled "Parenteral formulations of rasagiline." This patent provides a method for preferentially inhibiting monoamine oxidase A (MAOA) in the brain relative to the intestine. The formulation involves parenterally administering a controlled release formulation containing a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
Career Highlights
Aviva Gross is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her role at Teva has allowed her to contribute to groundbreaking research and development in the pharmaceutical sector.
Collaborations
Some of her notable coworkers include Cheryl Fitzer-Attas and Rom E Eliaz. Their collaborative efforts have further advanced the research and development initiatives at Teva.
Conclusion
Aviva Gross is a pioneering inventor whose work in parenteral formulations has the potential to significantly impact the treatment of various conditions. Her contributions to the field exemplify the importance of innovation in pharmaceuticals.